Literature DB >> 25894850

Tumor-Immune interactions: implications for cancer therapy.

Muly Tham1, Jean-Pierre Abastado.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25894850      PMCID： PMC4615046          DOI： 10.1080/15384101.2015.1032641

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells.

Authors:  Masahisa Jinushi; Shigeki Chiba; Hironori Yoshiyama; Kenkichi Masutomi; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Hideo Yagita; Akinori Takaoka; Hideaki Tahara
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

2.  Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Authors:  Carola H Ries; Michael A Cannarile; Sabine Hoves; Jörg Benz; Katharina Wartha; Valeria Runza; Flora Rey-Giraud; Leon P Pradel; Friedrich Feuerhake; Irina Klaman; Tobin Jones; Ute Jucknischke; Stefan Scheiblich; Klaus Kaluza; Ingo H Gorr; Antje Walz; Keelara Abiraj; Philippe A Cassier; Antonio Sica; Carlos Gomez-Roca; Karin E de Visser; Antoine Italiano; Christophe Le Tourneau; Jean-Pierre Delord; Hyam Levitsky; Jean-Yves Blay; Dominik Rüttinger
Journal:  Cancer Cell       Date:  2014-06-02       Impact factor: 31.743

3.  In vivo switching of human melanoma cells between proliferative and invasive states.

Authors:  Keith S Hoek; Ossia M Eichhoff; Natalie C Schlegel; Udo Döbbeling; Nikita Kobert; Leo Schaerer; Silvio Hemmi; Reinhard Dummer
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

4.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.

Authors:  Elsa Quintana; Mark Shackleton; Hannah R Foster; Douglas R Fullen; Michael S Sabel; Timothy M Johnson; Sean J Morrison
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

5.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

6.  Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation.

Authors:  Muly Tham; Kar Wai Tan; Jo Keeble; Xiaojie Wang; Sandra Hubert; Luke Barron; Nguan Soon Tan; Masashi Kato; Armelle Prevost-Blondel; Veronique Angeli; Jean-Pierre Abastado
Journal:  Oncotarget       Date:  2014-12-15

7.  Macrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma.

Authors:  Muly Tham; Karen Khoo; Kim Pin Yeo; Masashi Kato; Amelle Prevost-Blondel; Veronique Angeli; Jean-Pierre Abastado
Journal:  Oncotarget       Date:  2015-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.